台商在中國大陸經營原料藥廠的策略探討：以 AA 製藥有限公司為例

1990年代初期，中國大陸經濟尚未發展成熟，因考慮到當地投資成本相對較低，故部分台商決定於中國大陸市場投資。本研究之目的在於探討API製藥廠的成功案例如何克服投資風險，並藉此了解當中的投資及經營策略，透過分析中國大陸的原料藥市場發展的過程，了解其成功的關鍵及因素。研究方法分為文獻探討、優劣分析、藥物生產及研發分析。從各種面向探討API製藥廠的成功因素。透過對中國大陸市場之優劣分析及藥物研發分析，得出該API製藥廠之成功因素，包括時代因素、策略制定、國際影響等面向，種種因素造就了API藥廠的成功。本研究之目的在於分析個案的成功案例並供產業及學術界作為參考。

關鍵字

投資策略； API 藥物；藥廠經營；市場分析；藥物生產

並列摘要

In 1990s, Mainland China hadn’t reached the economic take-off stage, which means the market was not stable and consistent. Due to a lower cost of investment, most of the Taiwanese businessmen decided to invest into the market. This study aims to investigate the successful case of those Taiwanese businessmen, AA Pharmaceutical Co., Ltd. via different methods, for instance, the method of avoiding risk, analyzing the API market in Mainland China to find out the key of success. Literature review, SWOT analysis, pharmaceutical production and development analysis are the research methods used in this study. Through reaching in various angles, this study found out the factors of success of AA Pharmaceutical Co., Ltd. to be outstanding in the market of Mainland China. Through analyzing the advantages and disadvantages of mainland China market ,the study finds various factors of success, including time factor, decision making, global effects, etc. Various factors make the goals. The study aims to provide a useful reference to the industry and academic.